DE69326063D1 - Pharmazeutische und andere darreichungsformen - Google Patents

Pharmazeutische und andere darreichungsformen

Info

Publication number
DE69326063D1
DE69326063D1 DE69326063T DE69326063T DE69326063D1 DE 69326063 D1 DE69326063 D1 DE 69326063D1 DE 69326063 T DE69326063 T DE 69326063T DE 69326063 T DE69326063 T DE 69326063T DE 69326063 D1 DE69326063 D1 DE 69326063D1
Authority
DE
Germany
Prior art keywords
pharmaceutical
forms
pectin
carbon atoms
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69326063T
Other languages
English (en)
Other versions
DE69326063T2 (de
Inventor
Dilip Gole
Paul Wilkinson
J Davies
R Levinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Janssen Pharmaceutica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Inc filed Critical Janssen Pharmaceutica Inc
Publication of DE69326063D1 publication Critical patent/DE69326063D1/de
Application granted granted Critical
Publication of DE69326063T2 publication Critical patent/DE69326063T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70Fixation, conservation, or encapsulation of flavouring agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26DRYING
    • F26BDRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00Drying solid materials or objects by processes not involving the application of heat
DE69326063T 1992-05-06 1993-05-03 Pharmazeutische und andere darreichungsformen Expired - Lifetime DE69326063T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87975492A 1992-05-06 1992-05-06
PCT/US1993/004201 WO1993023017A1 (en) 1992-05-06 1993-05-03 Pharmaceutical and other dosage forms

Publications (2)

Publication Number Publication Date
DE69326063D1 true DE69326063D1 (de) 1999-09-23
DE69326063T2 DE69326063T2 (de) 2000-03-16

Family

ID=25374827

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326063T Expired - Lifetime DE69326063T2 (de) 1992-05-06 1993-05-03 Pharmazeutische und andere darreichungsformen

Country Status (28)

Country Link
EP (1) EP0642334B1 (de)
JP (1) JPH07508019A (de)
KR (1) KR100194241B1 (de)
CN (1) CN1085081A (de)
AT (1) ATE183387T1 (de)
BG (1) BG62681B1 (de)
CA (1) CA2135062C (de)
CL (1) CL2004001180A1 (de)
CY (1) CY2175B1 (de)
CZ (1) CZ283882B6 (de)
DE (1) DE69326063T2 (de)
DK (1) DK0642334T3 (de)
ES (1) ES2136662T3 (de)
FI (1) FI111333B (de)
GR (1) GR3031180T3 (de)
HK (1) HK1010693A1 (de)
HU (2) HU227532B1 (de)
IL (1) IL105553A (de)
MY (1) MY112231A (de)
NO (1) NO308065B1 (de)
NZ (1) NZ252526A (de)
PL (1) PL172354B1 (de)
RO (1) RO112990B1 (de)
RU (1) RU2131244C1 (de)
SG (1) SG47430A1 (de)
SK (1) SK280129B6 (de)
TW (1) TW380053B (de)
WO (1) WO1993023017A1 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
US5837276A (en) * 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
KR100782897B1 (ko) * 1996-06-17 2008-04-08 얀센 파마슈티카 엔.브이. 급속붕괴제형의표시방법
ES2172793T3 (es) 1996-06-17 2002-10-01 Janssen Pharmaceutica Nv Formas de dosificacion biconvexas de desintegracion rapida.
AU735071B2 (en) * 1996-06-17 2001-06-28 Janssen Pharmaceutica N.V. Marking rapidly disintegrating dosage forms
KR100823524B1 (ko) * 1996-06-17 2008-11-12 얀센 파마슈티카 엔.브이. 양쪽볼록형급속붕괴제형
GB9621614D0 (en) * 1996-10-17 1996-12-11 Cultech Limited Vitamin delivery
GB9802088D0 (en) * 1998-01-30 1998-03-25 Scherer Ltd R P Pharmaceutical products
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
PT1004656E (pt) 1998-11-11 2001-04-30 Dalli Werke Waesche & Koerperp Processo de fabrico e utilizacao de granulado compactado como desintegrante em corpos moldados por prensagem
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
FR2828380B1 (fr) * 2001-08-10 2005-07-29 Fontarome Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
MXPA04008171A (es) 2002-02-22 2004-11-26 Pharmacia Corp Formulacion oftalmica con sistema de goma.
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
AU2003262025A1 (en) * 2002-09-12 2004-04-30 Nihon Medi-Physics Co., Ltd. Preparation for controlling binging of drug to plasma protein
US20040052853A1 (en) * 2002-09-16 2004-03-18 Cp Kelco, U.S., Inc. Pectin films
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
EP2322195A2 (de) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
EP1797888A4 (de) 2004-09-28 2009-12-16 Senju Pharma Co Ophthalmische zusammensetzung mit xanthangummi und aminosäure
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005009241A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
CN101795704B (zh) * 2007-06-01 2014-07-30 协和发酵生化株式会社 经口组合物
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
SI2273983T1 (sl) 2008-05-09 2016-11-30 Gruenenthal Gmbh Postopek za pripravo intermediatne praškaste formulacije in končne trdne odmerne oblike z uporabo stopnje strjevanja z razprševanjem
JP2012533585A (ja) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化感受性オピオイドのための不正使用防止剤形
JP5667183B2 (ja) 2009-07-22 2015-02-12 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 加熱溶融押出成型した制御放出性投与剤型
TR201902233T4 (tr) 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
ES2486791T3 (es) 2010-09-02 2014-08-19 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
US20130028972A1 (en) 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
BR112014019988A8 (pt) 2012-02-28 2017-07-11 Gruenenthal Gmbh Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
ES2692944T3 (es) 2012-04-18 2018-12-05 Grünenthal GmbH Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
CA2931553C (en) 2013-11-26 2022-01-18 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
US9468606B2 (en) * 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
MX2017013637A (es) 2015-04-24 2018-03-08 Gruenenthal Gmbh Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB698767A (en) 1950-07-06 1953-10-21 Bayer Ag Readily soluble dry preparations of swelling substances
US2758644A (en) * 1953-07-30 1956-08-14 Virlouvet Jacques Control system for slatted roller blinds
US3234091A (en) 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE2017373A1 (de) 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
JPS5913887B2 (ja) 1979-10-30 1984-04-02 株式会社ブリヂストン 溶融金属用濾過材
DE3404382A1 (de) 1984-02-08 1985-08-14 Anton Dr. 4400 Münster Härle Saugflasche zum absaugen von sekreten aus wundhoehlen
US4697630A (en) * 1987-03-17 1987-10-06 General Clutch Corporation Tilt mechanism for venetian blinds
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
RU94046029A (ru) 1996-11-10
SG47430A1 (en) 1998-04-17
HU211549A9 (en) 1995-12-28
CN1085081A (zh) 1994-04-13
SK132094A3 (en) 1995-07-11
DK0642334T3 (da) 2000-04-17
EP0642334B1 (de) 1999-08-18
BG99158A (bg) 1995-05-31
CA2135062C (en) 1999-05-25
SK280129B6 (sk) 1999-08-06
ES2136662T3 (es) 1999-12-01
ATE183387T1 (de) 1999-09-15
PL172354B1 (pl) 1997-09-30
AU4232293A (en) 1993-12-13
FI945198A0 (fi) 1994-11-04
JPH07508019A (ja) 1995-09-07
CZ265494A3 (en) 1995-02-15
CY2175B1 (en) 2002-08-23
NO308065B1 (no) 2000-07-17
FI111333B (fi) 2003-07-15
MY112231A (en) 2001-05-31
GR3031180T3 (en) 1999-12-31
NO944207D0 (no) 1994-11-04
NO944207L (no) 1994-11-04
RO112990B1 (ro) 1998-03-30
IL105553A0 (en) 1993-08-18
KR950700728A (ko) 1995-02-20
DE69326063T2 (de) 2000-03-16
WO1993023017A1 (en) 1993-11-25
AU677198B2 (en) 1997-04-17
HU227532B1 (en) 2011-07-28
KR100194241B1 (ko) 1999-06-15
TW380053B (en) 2000-01-21
RU2131244C1 (ru) 1999-06-10
BG62681B1 (bg) 2000-05-31
EP0642334A1 (de) 1995-03-15
HUT68224A (en) 1995-06-28
CL2004001180A1 (es) 2005-06-03
IL105553A (en) 1998-01-04
CZ283882B6 (cs) 1998-06-17
HK1010693A1 (en) 1999-06-25
FI945198A (fi) 1994-11-04
NZ252526A (en) 1995-09-26
CA2135062A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
DE69326063D1 (de) Pharmazeutische und andere darreichungsformen
LV5749A4 (lv) Farmaceitiska kompozicija kas satur ciklosporinus
PT83873A (de) Arzneimittel mit antitumorwirkung
ATE493998T1 (de) Pharmazeutische zusammensetzung mit einem exendin-4-peptid
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
DE69426984T2 (de) Arzneizubereitung
ID28003A (id) Turunan-turunan adamantana
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69119810T2 (de) Pyrogensorbentmittel
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
NO894594D0 (no) Farmasoeytiske sammensetninger omfattende labdan diterpenoid-derivater og pyrimido(6,1-a)isoquinolin-4-ono-derivater.
DE69002881T2 (de) Peptide und deren Benutzung.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ES2089091T3 (es) Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
IT1224250B (it) Associzione del depiprazolo con la morfina
ATE134875T1 (de) Perorale applikationsform für peptidarzneistoffe, insbesondere insulin
DE68902056T2 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE68907893T2 (de) Neue 1,3,4,-thiadiazolderivate und antigeschwulstmittel, die diese enthalten.
ATE70840T1 (de) Benzothiepino(5,4-c>pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
ITMI921084A1 (it) Struttura di macchina da cucire perfezionata, particolarmente studiata per la cucitura di calzature e simili
ATE49956T1 (de) N,n-bis-(4fluorophenyl)carbamoylacetohydroxams|ure und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition